HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis
USA - NASDAQ:HLNE - US4074971064 - Common Stock
150.09 USD
+1.3 (+0.87%)
Overall HLNE gets a fundamental rating of 6 out of 10. We evaluated HLNE against 237 industry peers in the Capital Markets industry. HLNE has an excellent profitability rating, but there are some minor concerns on its financial health. HLNE shows excellent growth, but is valued quite expensive already. This makes HLNE very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year HLNE was profitable.
HLNE had a positive operating cash flow in the past year.
Each year in the past 5 years HLNE has been profitable.
HLNE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
HLNE has a Return On Assets of 11.78%. This is amongst the best in the industry. HLNE outperforms 92.41% of its industry peers.
With an excellent Return On Equity value of 27.96%, HLNE belongs to the best of the industry, outperforming 94.51% of the companies in the same industry.
HLNE's Return On Invested Capital of 18.59% is amongst the best of the industry. HLNE outperforms 95.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HLNE is significantly above the industry average of 7.61%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.78% | ||
| ROE | 27.96% | ||
| ROIC | 18.59% |
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
1.3 Margins
The Profit Margin of HLNE (30.66%) is better than 75.95% of its industry peers.
In the last couple of years the Profit Margin of HLNE has grown nicely.
Looking at the Operating Margin, with a value of 43.91%, HLNE is in the better half of the industry, outperforming 77.64% of the companies in the same industry.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.91% | ||
| PM (TTM) | 30.66% | ||
| GM | N/A |
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, HLNE has more shares outstanding
Compared to 5 years ago, HLNE has more shares outstanding
HLNE has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.13 indicates that HLNE is not in any danger for bankruptcy at the moment.
HLNE's Altman-Z score of 6.13 is amongst the best of the industry. HLNE outperforms 87.34% of its industry peers.
The Debt to FCF ratio of HLNE is 0.85, which is an excellent value as it means it would take HLNE, only 0.85 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.85, HLNE belongs to the top of the industry, outperforming 89.87% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that HLNE is not too dependend on debt financing.
The Debt to Equity ratio of HLNE (0.38) is better than 69.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 0.85 | ||
| Altman-Z | 6.13 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
The Current ratio of HLNE (1.16) is comparable to the rest of the industry.
A Quick Ratio of 1.16 indicates that HLNE should not have too much problems paying its short term obligations.
The Quick ratio of HLNE (1.16) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.80% over the past year.
Measured over the past years, HLNE shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.18% on average per year.
HLNE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.65%.
The Revenue has been growing by 21.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
3.2 Future
Based on estimates for the next years, HLNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.52% on average per year.
The Revenue is expected to grow by 14.19% on average over the next years. This is quite good.
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
EPS Next 5YN/A
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HLNE is valuated quite expensively with a Price/Earnings ratio of 31.01.
HLNE's Price/Earnings ratio is a bit more expensive when compared to the industry. HLNE is more expensive than 70.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. HLNE is around the same levels.
The Price/Forward Earnings ratio is 25.08, which means the current valuation is very expensive for HLNE.
64.98% of the companies in the same industry are cheaper than HLNE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HLNE to the average of the S&P500 Index (22.73), we can say HLNE is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.01 | ||
| Fwd PE | 25.08 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLNE is valued a bit cheaper than 66.67% of the companies in the same industry.
HLNE's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.74 | ||
| EV/EBITDA | 26.36 |
4.3 Compensation for Growth
The decent profitability rating of HLNE may justify a higher PE ratio.
A more expensive valuation may be justified as HLNE's earnings are expected to grow with 12.52% in the coming years.
PEG (NY)N/A
PEG (5Y)1.54
EPS Next 2Y8.96%
EPS Next 3Y12.52%
5. Dividend
5.1 Amount
HLNE has a Yearly Dividend Yield of 1.40%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.96, HLNE is paying slightly less dividend.
With a Dividend Yield of 1.40, HLNE pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.4% |
5.2 History
On average, the dividend of HLNE grows each year by 19.56%, which is quite nice.
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
37.04% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
The dividend of HLNE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP37.04%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
NASDAQ:HLNE (9/15/2025, 10:59:30 AM)
150.09
+1.3 (+0.87%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners104.24%
Inst Owner Change-8.62%
Ins Owners7.12%
Ins Owner Change-2.96%
Market Cap8.36B
Analysts49.09
Price Target166.06 (10.64%)
Short Float %6.19%
Short Ratio4.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.4% |
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP37.04%
Div Incr Years7
Div Non Decr Years7
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)1.1%
Max EPS beat(2)27.41%
EPS beat(4)3
Avg EPS beat(4)9.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)27.41%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)8
Avg EPS beat(12)10.1%
EPS beat(16)12
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)1.01%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)13.69%
Revenue beat(8)5
Avg Revenue beat(8)7.81%
Revenue beat(12)7
Avg Revenue beat(12)8.52%
Revenue beat(16)9
Avg Revenue beat(16)8.28%
PT rev (1m)2.26%
PT rev (3m)3.15%
EPS NQ rev (1m)1.27%
EPS NQ rev (3m)5.93%
EPS NY rev (1m)9.85%
EPS NY rev (3m)3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.83%
Revenue NY rev (1m)5.55%
Revenue NY rev (3m)6.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.01 | ||
| Fwd PE | 25.08 | ||
| P/S | 12.08 | ||
| P/FCF | 24.74 | ||
| P/OCF | 23.89 | ||
| P/B | 11.02 | ||
| P/tB | 11.02 | ||
| EV/EBITDA | 26.36 |
EPS(TTM)4.84
EY3.22%
EPS(NY)5.98
Fwd EY3.99%
FCF(TTM)6.07
FCFY4.04%
OCF(TTM)6.28
OCFY4.19%
SpS12.42
BVpS13.62
TBVpS13.62
PEG (NY)N/A
PEG (5Y)1.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.78% | ||
| ROE | 27.96% | ||
| ROCE | 22.22% | ||
| ROIC | 18.59% | ||
| ROICexc | 24.17% | ||
| ROICexgc | 24.88% | ||
| OM | 43.91% | ||
| PM (TTM) | 30.66% | ||
| GM | N/A | ||
| FCFM | 48.83% |
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexcg growth 3Y19.01%
ROICexcg growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 0.85 | ||
| Debt/EBITDA | 0.92 | ||
| Cap/Depr | 126.25% | ||
| Cap/Sales | 1.73% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 111.67% | ||
| Profit Quality | 159.29% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 6.13 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)7.8%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%-13.25%
EPS Next Y-0.5%
EPS Next 2Y8.96%
EPS Next 3Y12.52%
EPS Next 5YN/A
Revenue 1Y (TTM)10.65%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%-10.56%
Revenue Next Year8.46%
Revenue Next 2Y11.7%
Revenue Next 3Y14.19%
Revenue Next 5YN/A
EBIT growth 1Y8.35%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year-0.77%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y55.62%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y56.53%
OCF growth 3Y21.07%
OCF growth 5Y20.91%